177 related articles for article (PubMed ID: 37526372)
1. Neurologic Complications in Patients With Lymphoreticular Malignancy: A Descriptive Cohort Study.
Baloda R; Sharma S; Anand R; Mandal P; Parakh N; Katti B; Singh V; Chandra J
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e885-e891. PubMed ID: 37526372
[TBL] [Abstract][Full Text] [Related]
2. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
Parasole R; Petruzziello F; Menna G; Mangione A; Cianciulli E; Buffardi S; Marchese L; Nastro A; Misuraca A; Poggi V
Leuk Lymphoma; 2010 Jun; 51(6):1063-71. PubMed ID: 20470218
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for Central Nervous System thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: a single-centre cohort study.
Duarte X; Esteves S; Neto AM; Pereira F
Br J Haematol; 2016 Jul; 174(2):280-91. PubMed ID: 27018199
[TBL] [Abstract][Full Text] [Related]
5. [Neurologic complications during chemotherapy of children with acute lymphoid leukemia].
Kardos M; Grexa E; Kajtár P
Orv Hetil; 1992 May; 133(18):1111-5. PubMed ID: 1579351
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia.
Ray M; Marwaha RK; Trehan A
Indian J Pediatr; 2002 Feb; 69(2):185-7. PubMed ID: 11929036
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia.
Banerjee J; Niinimäki R; Lähteenmäki P; Hed Myrberg I; Arola M; Riikonen P; Lönnqvist T; Palomäki M; Ranta S; Harila-Saari A; Taskinen M
Pediatr Blood Cancer; 2020 Feb; 67(2):e27999. PubMed ID: 31674724
[TBL] [Abstract][Full Text] [Related]
8. Acute Central Nervous System Complications in Pediatric Acute Lymphoblastic Leukemia.
Baytan B; Evim MS; Güler S; Güneş AM; Okan M
Pediatr Neurol; 2015 Oct; 53(4):312-8. PubMed ID: 26202590
[TBL] [Abstract][Full Text] [Related]
9. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
[TBL] [Abstract][Full Text] [Related]
10. Treating childhood acute lymphoblastic leukemia without cranial irradiation.
Pui CH; Campana D; Pei D; Bowman WP; Sandlund JT; Kaste SC; Ribeiro RC; Rubnitz JE; Raimondi SC; Onciu M; Coustan-Smith E; Kun LE; Jeha S; Cheng C; Howard SC; Simmons V; Bayles A; Metzger ML; Boyett JM; Leung W; Handgretinger R; Downing JR; Evans WE; Relling MV
N Engl J Med; 2009 Jun; 360(26):2730-41. PubMed ID: 19553647
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy.
Śliwa-Tytko P; Kaczmarska A; Lejman M; Zawitkowska J
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628334
[TBL] [Abstract][Full Text] [Related]
12. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
[TBL] [Abstract][Full Text] [Related]
13. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
[TBL] [Abstract][Full Text] [Related]
14. [Complications in the central nervous system during chemotherapy for childhood acute lymphoblastic leukemia: JACLS ALL-02 study].
Umeda K; Yoshida M; Suzuki N; Endo M; Sato A; Hori H; Isogai M; Matsumoto K; Hara JI; Hasegawa D; Hashii Y; Chayama K; Miyaji R; Nishimura S; Tanizawa A; Uami I; Horibe K; Wakazono Y; Yagi K
Rinsho Ketsueki; 2007 Mar; 48(3):204-11. PubMed ID: 17441477
[TBL] [Abstract][Full Text] [Related]
15. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Experience of a single center using BFM protocols.
Çifçi Sunamak E; Özdemir N; Celkan T
Pediatr Blood Cancer; 2019 Jun; 66(6):e27711. PubMed ID: 30868749
[No Abstract] [Full Text] [Related]
16. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.
Winick NJ; Bowman WP; Kamen BA; Roach ES; Rollins N; Jacaruso D; Buchanan GR
J Natl Cancer Inst; 1992 Feb; 84(4):252-6. PubMed ID: 1734087
[TBL] [Abstract][Full Text] [Related]
17. Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.
Anastasopoulou S; Nielsen RL; Als-Nielsen B; Banerjee J; Eriksson MA; Helenius M; Heyman MM; Johannsdottir IM; Jonsson OG; MacGregor S; Mateos MK; Mayoh C; Mikkel S; Myrberg IH; Niinimäki R; Schmiegelow K; Taskinen M; Vaitkeviciene G; Warnqvist A; Wolthers B; Harila-Saari A; Ranta S
Haematologica; 2022 Oct; 107(10):2318-2328. PubMed ID: 35354251
[TBL] [Abstract][Full Text] [Related]
18. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
[TBL] [Abstract][Full Text] [Related]
19. Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.
Tsukamoto S; Takeuchi M; Kawajiri C; Tanaka S; Nagao Y; Sugita Y; Yamazaki A; Kawaguchi T; Muto T; Sakai S; Takeda Y; Ohwada C; Sakaida E; Shimizu N; Yokote K; Iseki T; Nakaseko C
Int J Hematol; 2012 Feb; 95(2):204-8. PubMed ID: 22160836
[TBL] [Abstract][Full Text] [Related]
20. Posterior Reversible Encephalopathy Syndrome in the Setting of Asparaginase-associated Pancreatitis in 2 Pediatric Patients With Acute Leukemia.
Scheuermann A; Harker-Murray P; Pommert L
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e709-e712. PubMed ID: 34966101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
